SwedenBIO - branschorganisationen för life science

Adenovir Pharma AB

Adenovir Pharma is developing the possibly first effective treatment of EKC. EKC (epidemic keratoconjunctivitis) is an eye infection caused by adenovirus – a worldwide problem which today lacks efficient treatment.

EKC is a highly contagious infectious disease which occurs worldwide sporadically and epidemically. It is considered a major health problem in many countries. The goal is to develop a topical antiviral pharmaceutical product for treatment and potential use for prevention of adenoviral conjunctivitis, Epidemic keratoconjunctivitis (EKC).

Kategorier: Pharma

Gå till Adenovir Pharma ABs hemsida